These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 38568384)

  • 1. The outcome of genetic and non-genetic pediatric cardiomyopathies.
    AlAlakhfash A; Agati L; Mazzesi G; Elhobi D; Alqwaiee A; Alhory K; Almesned A; Alhasnan Z; Alwadai A
    Egypt Heart J; 2024 Apr; 76(1):43. PubMed ID: 38568384
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Phenotype and Outcome of Infantile Cardiomyopathy Caused by a Homozygous ELAC2 Mutation.
    Shinwari ZMA; Almesned A; Alakhfash A; Al-Rashdan AM; Faqeih E; Al-Humaidi Z; Alomrani A; Alghamdi M; Colak D; Alwadai A; Rababh M; Al-Fayyadh M; Al-Hassnan ZN
    Cardiology; 2017; 137(3):188-192. PubMed ID: 28441660
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The clinical profile, genetic basis and survival of childhood cardiomyopathy: a single-center retrospective study.
    Yuan W; Jia Z; Li J; Liu L; Tian J; Huang X; Quan J
    Eur J Pediatr; 2024 Mar; 183(3):1389-1401. PubMed ID: 38165464
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical Characteristics and Contemporary Management of Patients With Cardiomyopathies in Japan　- Report From a National Registry of Clinical Personal Records.
    Enzan N; Matsushima S; Ide T; Kaku H; Tohyama T; Funakoshi K; Higo T; Tsutsui H;
    Circ Rep; 2021 Feb; 3(3):142-152. PubMed ID: 33738347
    [No Abstract]   [Full Text] [Related]  

  • 5. Epidemiologic and clinical characteristics of cardiomyopathies in Japan: results from nationwide surveys.
    Matsumori A; Furukawa Y; Hasegawa K; Sato Y; Nakagawa H; Morikawa Y; Miura K; Ohno Y; Tamakoshi A; Inaba Y; Sasayama S;
    Circ J; 2002 Apr; 66(4):323-36. PubMed ID: 11954944
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Feline Cardiomyopathies: 3. Cardiomyopathies other than HCM.
    Kittleson MD; Côté E
    J Feline Med Surg; 2021 Nov; 23(11):1053-1067. PubMed ID: 34693805
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Artificial intelligence study on left ventricular function among normal individuals, hypertrophic cardiomyopathy and dilated cardiomyopathy patients using 1.5T cardiac cine MR images obtained by SSFP sequence.
    Guo J; Lu H; Chen Y; Zeng M; Jin H
    Br J Radiol; 2022 May; 95(1133):20201060. PubMed ID: 35084208
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cardiac Biomarkers in Pediatric Cardiomyopathy: Study Design and Recruitment Results from the Pediatric Cardiomyopathy Registry.
    Everitt MD; Wilkinson JD; Shi L; Towbin JA; Colan SD; Kantor PF; Canter CE; Webber SA; Hsu DT; Pahl E; Addonizio LJ; Dodd DA; Jefferies JL; Rossano JW; Feingold B; Ware SM; Lee TM; Godown J; Simpson KE; Sleeper LA; Czachor JD; Razoky H; Hill A; Westphal J; Molina KM; Lipshultz SE;
    Prog Pediatr Cardiol; 2019 Jun; 53():1-10. PubMed ID: 31745384
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence and Disease Expression of Pathogenic and Likely Pathogenic Variants Associated With Inherited Cardiomyopathies in the General Population.
    Bourfiss M; van Vugt M; Alasiri AI; Ruijsink B; van Setten J; Schmidt AF; Dooijes D; Puyol-Antón E; Velthuis BK; van Tintelen JP; Te Riele ASJM; Baas AF; Asselbergs FW
    Circ Genom Precis Med; 2022 Dec; 15(6):e003704. PubMed ID: 36264615
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetic evaluation of cardiomyopathies in Qatar identifies enrichment of pathogenic sarcomere gene variants and possible founder disease mutations in the Arabs.
    Al-Shafai KN; Al-Hashemi M; Manickam C; Musa R; Selvaraj S; Syed N; Vempalli F; Ali M; Yacoub M; Estivill X
    Mol Genet Genomic Med; 2021 Jul; 9(7):e1709. PubMed ID: 34137518
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cardiac MRI findings to differentiate athlete's heart from hypertrophic (HCM), arrhythmogenic right ventricular (ARVC) and dilated (DCM) cardiomyopathy.
    Kübler J; Burgstahler C; Brendel JM; Gassenmaier S; Hagen F; Klingel K; Olthof SC; Blume K; Wolfarth B; Mueller KAL; Greulich S; Krumm P
    Int J Cardiovasc Imaging; 2021 Aug; 37(8):2501-2515. PubMed ID: 34019206
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Outcomes of children with cardiomyopathy listed for transplant: a multi-institutional study.
    Dipchand AI; Naftel DC; Feingold B; Spicer R; Yung D; Kaufman B; Kirklin JK; Allain-Rooney T; Hsu D;
    J Heart Lung Transplant; 2009 Dec; 28(12):1312-21. PubMed ID: 19782592
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Unclassified cardiomyopathies: subspecies and their transformation].
    Ikeda Y; Kawai S; Okada R; Yamaguchi H
    J Cardiol; 1998 Feb; 31(2):91-7. PubMed ID: 9513036
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical profile and outcome of cardiomyopathies in infants and children seen at a tertiary centre.
    Pagano M; Fumagalli C; Girolami F; Passantino S; Gozzini A; Brambilla A; Spinelli V; Morrone A; Procopio E; Pochiero F; Donati MA; Olivotto I; Favilli S
    Int J Cardiol; 2023 Jan; 371():516-522. PubMed ID: 36130621
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Myocardial diseases in Thai children.
    Soongswang J; Sangtawesin C; Sittiwangkul R; Wanitkun S; Muangmingsuk S; Sopontammarak S; Klungratana C; Kangkagate C
    J Med Assoc Thai; 2002 Aug; 85 Suppl 2():S648-57. PubMed ID: 12403243
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Signaling network model of cardiomyocyte morphological changes in familial cardiomyopathy.
    Khalilimeybodi A; Riaz M; Campbell SG; Omens JH; McCulloch AD; Qyang Y; Saucerman JJ
    J Mol Cell Cardiol; 2023 Jan; 174():1-14. PubMed ID: 36370475
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Familial risk of dilated and hypertrophic cardiomyopathy: a national family study in Sweden.
    Ricci F; Banihashemi B; Pirouzifard M; Sundquist J; Sundquist K; Sutton R; Fedorowski A; Zöller B
    ESC Heart Fail; 2023 Feb; 10(1):121-132. PubMed ID: 36169166
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metabolite Signature in the Carriers of Pathogenic Genetic Variants for Cardiomyopathy: A Population-Based METSIM Study.
    Ravi R; Fernandes Silva L; Vangipurapu J; Maria M; Raivo J; Helisalmi S; Laakso M
    Metabolites; 2022 May; 12(5):. PubMed ID: 35629941
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cardiac magnetic resonance and galectin-3 level as predictors of prognostic outcomes for non-ischemic cardiomyopathy patients.
    Hu DJ; Xu J; Du W; Zhang JX; Zhong M; Zhou YN
    Int J Cardiovasc Imaging; 2016 Dec; 32(12):1725-1733. PubMed ID: 27566192
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognosis after heart transplant in patients with hypertrophic and restrictive cardiomyopathy. A nationwide registry analysis.
    González-Urbistondo F; Almenar-Bonet L; Gómez-Bueno M; Crespo-Leiro M; González-Vílchez F; García-Cosío MD; López-Granados A; Mirabet S; Martínez-Sellés M; Sobrino JM; Díez-López C; Farrero M; Díaz-Molina B; Rábago G; de la Fuente-Galán L; Garrido-Bravo I; Blasco-Peiró MT; García-Quintana A; Vázquez de Prada JA
    Rev Esp Cardiol (Engl Ed); 2024 Apr; 77(4):304-313. PubMed ID: 37984703
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.